載入...
Cardiovascular Effects of Erythropoietin: An Update
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of EPO and its receptor (EPOR) in the cardiovascular system expanded understanding of physiological and pathophysiolog...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3907121/ https://ncbi.nlm.nih.gov/pubmed/21081221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-385061-4.00009-X |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|